In Association With Novotech

Accelerating Clinical Trials

Partner Content

Cervical cancer: Navigating today’s global clinical trial landscape

Partner Content

Pancreatic cancer: The clinical trial landscape and progress for 2024

Partner Content

Oesophageal cancer: the global clinical trials landscape in 2024

Partner Content

Chronic Lymphocytic Leukaemia: the global clinical trials landscape in 2024

Partner Content

Non-small cell lung cancer: the global clinical trials landscape 2024

Partner Content

Navigating the global epilepsy clinical trial landscape in 2024

Partner Content

Cystic fibrosis: global clinical trials landscape and treatments

Partner Content

Duchenne Muscular Dystrophy: the global clinical trials landscape 2024

Partner Content

Expert analysis: the latest in HIV research and clinical trials

Analyst Comment

EASD 2023: efficacy of initial TCT in drug-naïve patients with T2D

GlobalData Healthcare

Accelerating Clinical Trials

How a drug development plan can save your biotech money

Accelerating Clinical Trials

The benefit of running clinical trials in Asia-Pacific for biotech companies

Accelerating Clinical Trials

Is Australia the future for successful first-in-human clinical studies?

Partner Content

How biotechs can tap APAC for excellence in oncology trials

Partner Content

Why Asia-Pacific attracts 60% of all ongoing and planned hepatology trials globally

Partner Content

Clinical Trial Continuity in Asia-Pacific during the COVID-19 pandemic

Partner Content

Biotechs testing for COVID-19 in Asia-Pacific benefit from new fast-track review processes

Partner Content

Data shows majority of Australian sites are open for clinical trial activity

Partner Content

Managing the Covid-19 outbreak: Lessons learnt from South Korea

Partner Content

Clinical trials data report for Asia-Pacific: Frost & Sullivan collaborates with Novotech

Partner Content

Novotech case study: Global reach through CRO partnership for a phase 2 oncology trial

Partner Content

Case studies in accelerating clinical trials in oncology

Partner Content

Regulatory requirements for clinical trials: A comparison of Australia and the US

Most Popular

Partner Content

Cervical cancer: Navigating today’s global clinical trial landscape

Partner Content

Pancreatic cancer: The clinical trial landscape and progress for 2024

Partner Content

Oesophageal cancer: the global clinical trials landscape in 2024

Partner Content

Chronic Lymphocytic Leukaemia: the global clinical trials landscape in 2024

White Papers

Novotech

HIV – Global Clinical Trial Landscape

HIV – Global Clinical Trial Landscape

Duchenne Muscular Dystrophy - Global Clinical Trial Landscape (2024)

Cystic Fibrosis – Global Clinical Trial Landscape (2024)

Epilepsy - Global Clinical Trial Landscape (2024)

Non-Small Cell Lung Cancer - Global Clinical Trial Landscape (2024)

Chronic Lymphocytic Leukemia: Global Clinical Trial Landscape (2024)

Oesophageal Cancer - Global Clinical Trial Landscape (2024)

Pancreatic Cancer Global Clinical Trial Landscape (2024)

Cervical Cancer – Global Clinical Trial Landscape (2024)

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close